Stephanie L. Graff, MD FACP FASCO
@drsgraff.bsky.social
Director Breast Oncology, Brown University Health Cancer Institute, Legorreta Cancer Center Brown Univ| #bcsm #clinicaltrials #oncology | Views Mine
“In giving, we are connected. Gifts speak for us when the weight of emotion and the vulnerability of truth are too much.”
Brown Paper Bags | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Brown Paper Bags | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Brown Paper Bags
ascopubs.org
August 29, 2025 at 5:06 PM
“In giving, we are connected. Gifts speak for us when the weight of emotion and the vulnerability of truth are too much.”
Brown Paper Bags | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Brown Paper Bags | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
“Who decides who decides?”
Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias
#MedSky #WomenInMedicine
ascopubs.org/doi/10.1200/...
Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias
#MedSky #WomenInMedicine
ascopubs.org/doi/10.1200/...
Invisible in the Metrics of Academic Oncology | JCO Oncology Practice
ascopubs.org
June 24, 2025 at 1:33 PM
“Who decides who decides?”
Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias
#MedSky #WomenInMedicine
ascopubs.org/doi/10.1200/...
Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias
#MedSky #WomenInMedicine
ascopubs.org/doi/10.1200/...
⛱️☀️📖 You have heard of “light summer beach reads” — and now @JCO_ASCO brings you “stirring, emotionally powerful, reflective narrative summer writing” (practically the same, right??)
But really, what a wonderful opportunity for young writers. ✍🏻📝👨💻 @oncoalert.bsky.social
But really, what a wonderful opportunity for young writers. ✍🏻📝👨💻 @oncoalert.bsky.social
Announcing the first EVER @ascocancer.bsky.social JCO Art of Oncology Narrative Medicine Contest! 🎉✍️🎗️🩺🎉
We're looking for essays that explore the human experience of cancer and reflect on the experience of trainees and early career hematologists/oncologists. Apply Now! ascopubs.org/jco/art-onco...
We're looking for essays that explore the human experience of cancer and reflect on the experience of trainees and early career hematologists/oncologists. Apply Now! ascopubs.org/jco/art-onco...
Art of Oncology Narrative Medicine Contest | Journal of Clinical Oncology
ascopubs.org
June 12, 2025 at 9:13 PM
⛱️☀️📖 You have heard of “light summer beach reads” — and now @JCO_ASCO brings you “stirring, emotionally powerful, reflective narrative summer writing” (practically the same, right??)
But really, what a wonderful opportunity for young writers. ✍🏻📝👨💻 @oncoalert.bsky.social
But really, what a wonderful opportunity for young writers. ✍🏻📝👨💻 @oncoalert.bsky.social
ASCENT04 changes practice w/ improved mPFS 11.2 vs. 7.8 mos; 12 mon PFS 48 vs 33 mos w/ impressive tail suggesting potential for group with durable sustained response; adverse events were not additive. Bonus points for cr up oss over design. #ASCO25 @oncoalert.bsky.social
May 31, 2025 at 8:45 PM
ASCENT04 changes practice w/ improved mPFS 11.2 vs. 7.8 mos; 12 mon PFS 48 vs 33 mos w/ impressive tail suggesting potential for group with durable sustained response; adverse events were not additive. Bonus points for cr up oss over design. #ASCO25 @oncoalert.bsky.social
VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social
@oncoalert.bsky.social #ASCO25
@oncoalert.bsky.social #ASCO25
May 31, 2025 at 7:00 PM
VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social
@oncoalert.bsky.social #ASCO25
@oncoalert.bsky.social #ASCO25
Reflex cDNA-methylation multi-cancer early detection (MCED) test achieved meaningful per-cancer intrinsic accuracy & per-tissue of origin PPV across mult cancer types evaluated in at-risk indiv w/obesity. #ASCO25 @oncoalert.bsky.social
May 31, 2025 at 1:47 PM
Reflex cDNA-methylation multi-cancer early detection (MCED) test achieved meaningful per-cancer intrinsic accuracy & per-tissue of origin PPV across mult cancer types evaluated in at-risk indiv w/obesity. #ASCO25 @oncoalert.bsky.social
The chemo-free combo of Ribo+Let+trastuzumab led to mOFS 30.4 months, good ORR, and minimal cardiac toxicity in this ph2 1L Korean study. #ASCO25 @oncoalert.bsky.social
May 30, 2025 at 8:30 PM
The chemo-free combo of Ribo+Let+trastuzumab led to mOFS 30.4 months, good ORR, and minimal cardiac toxicity in this ph2 1L Korean study. #ASCO25 @oncoalert.bsky.social
Dr. @hoperugo.bsky.social presents data from 5️⃣ 🇺🇸centers on re-challenge after G1 ILD with T-DXd (n=44), and a small # (n=19) G2 ILD rechallenged.
27% of G1 rechallenged had a second event; 16% of the G2 patients had a second event #ASCO25
@oncoalert.bsky.social
27% of G1 rechallenged had a second event; 16% of the G2 patients had a second event #ASCO25
@oncoalert.bsky.social
May 30, 2025 at 8:12 PM
Dr. @hoperugo.bsky.social presents data from 5️⃣ 🇺🇸centers on re-challenge after G1 ILD with T-DXd (n=44), and a small # (n=19) G2 ILD rechallenged.
27% of G1 rechallenged had a second event; 16% of the G2 patients had a second event #ASCO25
@oncoalert.bsky.social
27% of G1 rechallenged had a second event; 16% of the G2 patients had a second event #ASCO25
@oncoalert.bsky.social
Kicking off breast sessions #ASCO25 with the data that Black patients with breast cancer continue to have worse overall survival in the modern-HER2 era. Adjusted HR 1.28 @oncoalert.bsky.social
May 30, 2025 at 7:55 PM
Kicking off breast sessions #ASCO25 with the data that Black patients with breast cancer continue to have worse overall survival in the modern-HER2 era. Adjusted HR 1.28 @oncoalert.bsky.social
Reposted by Stephanie L. Graff, MD FACP FASCO
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
May 23, 2025 at 10:05 AM
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Join me & Maryam Lustberg at #ASCO25 at #OncForum2025 to discuss ADCs, sequencing, HER2 low/ultra-low, biomarkers, and “right-sizing” early stage disease
Saturday June 1 at 7:15- 7:45 PM
Duneyrr Fermenta & Brewery
2337 S. Michigan Ave.
Register now! app.smartsheet.com/b/form/7e557...
Saturday June 1 at 7:15- 7:45 PM
Duneyrr Fermenta & Brewery
2337 S. Michigan Ave.
Register now! app.smartsheet.com/b/form/7e557...
May 24, 2025 at 10:38 AM
Join me & Maryam Lustberg at #ASCO25 at #OncForum2025 to discuss ADCs, sequencing, HER2 low/ultra-low, biomarkers, and “right-sizing” early stage disease
Saturday June 1 at 7:15- 7:45 PM
Duneyrr Fermenta & Brewery
2337 S. Michigan Ave.
Register now! app.smartsheet.com/b/form/7e557...
Saturday June 1 at 7:15- 7:45 PM
Duneyrr Fermenta & Brewery
2337 S. Michigan Ave.
Register now! app.smartsheet.com/b/form/7e557...
Honored and humbled to be awarded the 2025 E. Grey Diamond Take Wing Award, my school’s highest alumni honor. Thank you, Dean Norbash, my amazing family, members of the awards committee— I am proud to embody the spirit of UMKC SOM in all that I do.
May 16, 2025 at 9:13 PM
Honored and humbled to be awarded the 2025 E. Grey Diamond Take Wing Award, my school’s highest alumni honor. Thank you, Dean Norbash, my amazing family, members of the awards committee— I am proud to embody the spirit of UMKC SOM in all that I do.
In <1 minute, use @ascocancer.bsky.social link to #ProtectMedicaid. Maybe you think it isn’t about you—but sometimes patients w/cancer lose their job, insurance is tied to employment, then suddenly—Medicaid is about them. Urge members of congress to safeguard Medicaid ➡️brnw.ch/21wSxkd
May 10, 2025 at 12:23 AM
In <1 minute, use @ascocancer.bsky.social link to #ProtectMedicaid. Maybe you think it isn’t about you—but sometimes patients w/cancer lose their job, insurance is tied to employment, then suddenly—Medicaid is about them. Urge members of congress to safeguard Medicaid ➡️brnw.ch/21wSxkd
Reposted by Stephanie L. Graff, MD FACP FASCO
Congress is considering cuts to Medicaid during its budget reconciliation process. 70 million ppl receive health coverage under Medicaid, including those w/ cancer. We must #ProtectMedicaid! #ASCOAdvocacy
Urge members of congress to safeguard Medicaid➡️ brnw.ch/21wSxGD
Urge members of congress to safeguard Medicaid➡️ brnw.ch/21wSxGD
May 9, 2025 at 8:40 PM
Congress is considering cuts to Medicaid during its budget reconciliation process. 70 million ppl receive health coverage under Medicaid, including those w/ cancer. We must #ProtectMedicaid! #ASCOAdvocacy
Urge members of congress to safeguard Medicaid➡️ brnw.ch/21wSxGD
Urge members of congress to safeguard Medicaid➡️ brnw.ch/21wSxGD
Oncologists—
The @ascocancer.bsky.social #ASCO24 #IDEA awardees are conducting a study to understand and identify barriers, opportunities, and strategies to improve evidence-based cancer care globally. Take a quick survey here:
forms.office.com/pages/respon...
Cc. @oncoalert.bsky.social
The @ascocancer.bsky.social #ASCO24 #IDEA awardees are conducting a study to understand and identify barriers, opportunities, and strategies to improve evidence-based cancer care globally. Take a quick survey here:
forms.office.com/pages/respon...
Cc. @oncoalert.bsky.social
Microsoft Forms
forms.office.com
April 22, 2025 at 1:15 PM
Oncologists—
The @ascocancer.bsky.social #ASCO24 #IDEA awardees are conducting a study to understand and identify barriers, opportunities, and strategies to improve evidence-based cancer care globally. Take a quick survey here:
forms.office.com/pages/respon...
Cc. @oncoalert.bsky.social
The @ascocancer.bsky.social #ASCO24 #IDEA awardees are conducting a study to understand and identify barriers, opportunities, and strategies to improve evidence-based cancer care globally. Take a quick survey here:
forms.office.com/pages/respon...
Cc. @oncoalert.bsky.social
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
www.gilead.com
April 21, 2025 at 11:14 PM
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
I just had to explain the expression “burning the candle at both ends” to my 9yo. But, yep. #currentsituation
April 16, 2025 at 10:29 PM
I just had to explain the expression “burning the candle at both ends” to my 9yo. But, yep. #currentsituation
In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
PURPOSEAdjuvant endocrine therapy (ET) improves overall survival (OS) in estrogen receptor
(ER)–positive early-stage breast cancer (BC). However, the benefit of ET for those
with ER-low BC (ER 1%-10%)...
ascopubs.org
April 13, 2025 at 12:44 PM
In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Check out this cool profile on all things @dramycomander.bsky.social and Lifestyle Oncology!! @oncologytimes.bsky.social
journals.lww.com/oncology-tim...
journals.lww.com/oncology-tim...
The Essential Connection Between Healthy Lifestyle & Cancer ... : Oncology Times
An abstract is unavailable.
journals.lww.com
April 12, 2025 at 12:45 PM
Check out this cool profile on all things @dramycomander.bsky.social and Lifestyle Oncology!! @oncologytimes.bsky.social
journals.lww.com/oncology-tim...
journals.lww.com/oncology-tim...
REAL ID will be *really real* by #ASCO25 —make sure your ID is airport ready. ✈️
@ascocancer.bsky.social @oncbrothers.bsky.social @oncoalert.bsky.social @narjustflorezmd.bsky.social @drchoueiri.bsky.social @erikahamilton9.bsky.social @drdonsdizon.bsky.social @drteplinsky.bsky.social
@ascocancer.bsky.social @oncbrothers.bsky.social @oncoalert.bsky.social @narjustflorezmd.bsky.social @drchoueiri.bsky.social @erikahamilton9.bsky.social @drdonsdizon.bsky.social @drteplinsky.bsky.social
Driver's licenses and IDs that are not Real ID-compliant will no longer get you through U.S. airport security once the law takes effect in a few weeks, but full enforcement may not start right away.
What you need to know as the May 7 Real ID deadline approaches
Driver's licenses and IDs that are not Real ID-compliant will no longer get you through U.S. airport security once the law takes effect in a few weeks, but full enforcement may not start right away.
www.npr.org
April 11, 2025 at 2:31 AM
REAL ID will be *really real* by #ASCO25 —make sure your ID is airport ready. ✈️
@ascocancer.bsky.social @oncbrothers.bsky.social @oncoalert.bsky.social @narjustflorezmd.bsky.social @drchoueiri.bsky.social @erikahamilton9.bsky.social @drdonsdizon.bsky.social @drteplinsky.bsky.social
@ascocancer.bsky.social @oncbrothers.bsky.social @oncoalert.bsky.social @narjustflorezmd.bsky.social @drchoueiri.bsky.social @erikahamilton9.bsky.social @drdonsdizon.bsky.social @drteplinsky.bsky.social
The act will disenfranchise vets/active/overseas military from voting as well (who often have less access to reams of documents)
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/…#HellNoN#VotesForVetsts
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/…#HellNoN#VotesForVetsts
April 10, 2025 at 6:33 PM
The act will disenfranchise vets/active/overseas military from voting as well (who often have less access to reams of documents)
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/…#HellNoN#VotesForVetsts
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/…#HellNoN#VotesForVetsts
Married women who have their husbands last name may need to show 3+ legal documents to verify voter eligibility
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans -
#HellNo #VotesForWomen
www.naacpldf.org/press-releas...
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans -
#HellNo #VotesForWomen
www.naacpldf.org/press-releas...
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans
LDF urges the U.S. Senate to reject the misleadingly entitled “Safeguard American Voter Eligibility (SAVE) Act”, a disastrous, discriminatory, inefficient, and unnecessary bill passed by the House that would disenfranchise millions of eligible voters.
www.naacpldf.org
April 10, 2025 at 6:32 PM
Married women who have their husbands last name may need to show 3+ legal documents to verify voter eligibility
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans -
#HellNo #VotesForWomen
www.naacpldf.org/press-releas...
LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans -
#HellNo #VotesForWomen
www.naacpldf.org/press-releas...
This ⬇️
I just learned that the entire press team at the FDA was fired last week. The *entire* press team.
It's difficult to grasp how bizarre this is.
To wrap my brain around the idea, I made a list of things the FDA is responsible for, and that reporters now have no one at the agency to ask about... 🧪🛟
It's difficult to grasp how bizarre this is.
To wrap my brain around the idea, I made a list of things the FDA is responsible for, and that reporters now have no one at the agency to ask about... 🧪🛟
April 8, 2025 at 11:50 PM
This ⬇️
Reposted by Stephanie L. Graff, MD FACP FASCO
Justice Sotomayor with a bone-chilling dissent today: “The implication of the govt’s position is noncitizens AND US citizens could be taken off streets, forced onto planes, confined to foreign prisons with no opportunity for redress…This Nation's laws is designed to prevent, not en-able, their rise.
April 8, 2025 at 3:33 AM
Justice Sotomayor with a bone-chilling dissent today: “The implication of the govt’s position is noncitizens AND US citizens could be taken off streets, forced onto planes, confined to foreign prisons with no opportunity for redress…This Nation's laws is designed to prevent, not en-able, their rise.